12 documents found, page 1 of 2
Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular L...
Maan, R; Lauw, MN; China, L; Patch, D; Baiges, A; Garcia-Pagan, JC; Hernández-Gea, V; Hilleret, MN; Tjwa, ET; Kounis, I; Bureau, C; Giguet, B"Background and aims: Since the introduction of SARS-CoV-2 vaccines, several cases of vaccine-induced immune thrombocytopenia and thrombosis (VITT) have been described, especially cerebral vein thrombosis. We aimed to retrospectively collect all new cases of acute onset first or recurrent splanchnic vein thrombosis (SVT) following a recent SARS-CoV-2 vaccination within the Vascular Liver Disease Group network. ...
Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Dis...
da Costa, RQ; Laranjeira, F; Ribeiro, ID; Santos, AF; Nery, FMetabolic associated fatty liver disease became the most common form of chronic liver disease, in the vast majority of the cases related to increased insulin resistance or metabolic dysregulation. Yet, other causes may be implied. We report the late diagnosis of Dorfman-Chanarin syndrome in a non-alcoholic steatohepatitis previously labeled cirrhotic middle-aged man, with consanguineous parents, complicated wit...
Ethics in Authorship: Considerations and Concerns
Pinho, I; Pinho, J; Nery, FNo abstract available
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis:...
Nery, F; Carneiro, P; Correia, S; Macedo, C; Gandara, J; Lopes, V; Valadares, D; Ferreira, S; Oliveira, J; Teixeira Gomes, M; Miranda, HP; Rautou, PEBackground and Aims Various risk factors for portal vein thrombosis (PVT) development in patients with cirrhosis have been identified, but the role of systemic inflammatory reaction is unknown. The study aims to assess the association between markers of systemic inflammation and PVT in cirrhosis. Methods Between January 2014 and October 2015, 107 outpatients with cirrhosis and no PVT were recruited, and followe...
Pleural Effusion Related to Chronic Hepatitis B Virus Reactivation: A Rare Asso...
Oliveira, A; Valadares, D; Nery, FDespite worldwide vaccination campaigns, hepatitis B virus (HBV) infection remains a major public health problem. The natural history ranges from asymptomatic infection to severe liver injury or failure, chronic complications or reactivation episodes. The effects of HBV on the organism are immunomediated, possibly triggering extrahepatic manifestations. Since 1971, only a few cases of pleural effusion related t...
The Role of a Medical Intermediate Care Unit in the Management of Budd-Chiari S...
Cravo, M; Oliveira, DG; Guimas, A; Vita, P; Rego, AL; Alves, R; Valadares, D; Carvalheiras, G; Ricardo, M; Pinto, A; Pessegueiro, H; Nery, FBudd-Chiari syndrome (BCS) has a wide spectrum of presentations, from an asymptomatic status to acute liver failure (ALF). The therapeutic approach depends on disease severity and related etiology with patients with severe forms of presentation classically managed in intensive care units (ICUs). Here, we report a series of five BCS patients managed in a medical intermediate care unit (IntCU), with three of them...
Budd-Chiari Syndrome and Acute Liver Failure: An Uncommon Presentation of Acute...
Costa, ARG; Freitas, I; Raposo, J; Barbosa, G; Miranda, HP; Nery, FAcute liver failure (ALF) is a rare entity, particularly in the context of Budd-Chiari syndrome (BCS). BCS is an uncommon disorder with multiple risk factors, most commonly myeloproliferative disorders. In BCS, active search and exclusion of underlying malignancy is mandatory, particularly in the context of ALF, as it may contraindicate liver transplantation (LT). We present the case of a healthy 29-year-old ma...
Improvement of Central Nervous System Vasculitis in a Patient with Chronic Hepa...
Lima, S; Faria, R; Nery, FBackground: Neurosarcoidosis is a rare manifestation of hepatitis C virus (HCV) infection, mainly in patients exposed to interferon-based therapies. Although we are living in a new era of HCV treatment, there is still little data concerning the treatment of extrahepatic complications of the disease with direct antiviral agents, especially rare ones such as neurosarcoidosis. Summary: We present a rare case of ce...
Letter: nonselective beta-blockers, endoscopic therapy and portal vein thrombos...
Nery, F; Valla, Dn/a
Porto-sinusoidal vascular disease: proposal and description of a novel entity
De Gottardi, A; Rautou, PE; Schouten, J; Rubbia-Brandt, L; Leebeek, F; Trebicka, J; Murad, SD; Vilgrain, V; Hernandez-Gea, V; Nery, F; Plessier, APortal hypertension in the absence of portal vein thrombosis and without cirrhosis, but with mild or moderate alterations of liver histology (eg, obliterative venopathy, nodular regenerative hyperplasia, or incomplete septal cirrhosis) is being increasingly recognised. Owing to the heterogeneity of causes and histological findings, a substantial number of terms have been used to describe such idiopathic non-cir...